Hosted on MSN23m
Celltrion gets U.S. FDA approval for new biosimilar for autoimmune disease treatmentCelltrion Inc., a major South Korean biopharmaceutical firm, said Friday its new biosimilar for an autoimmune disease treatment has received approval from the U.S. Food and Drug Administration (FDA).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback